EN CN
EN CN

2019/02/28 10:00

PREVIOUS ARTICLE CANbridge Pharmaceuticals and WuXi Biologics Expand Rare Disease Therapeutics Partnership NEXT ARTICLE CANbridge Pharmaceuticals Appoints Chief Financial Officer and Interim Chief Medical Officer